GLP-1 drugs are all the rage—but patients are quitting them too fast to achieve meaningful weight loss, study finds
Sales of anti-obesity drugs hit $1.1 billion in the second quarter of 2023.
Stay updated with breaking news from Andrew Nusca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sales of anti-obesity drugs hit $1.1 billion in the second quarter of 2023.
Venture capital investors at Fortune's recent Brainstorm Health summit gave a tough, but encouraging prognosis for health tech startups.
LAMs are an emerging type of model that essentially turn LLMs into assistants.
Corporate technology leaders are on the front lines of rolling out AI services. During a dinner hosted by Fortune, they shared their hopes, fears, and challenges.
He worked as a busboy at Denny’s, graduated high school at 16, and got the Nvidia logo tattooed on his bicep when the stock price hit $100.